Last Updated

26 Nov 2019

Amphoteric polyamidoamines as innovative tools to selectively direct antimalarial drugs towards Plasmodium-infected red blood cells

Objectives

The main objective of this project is the development of polyamidoamine-based polymeric nanoparticles for the delivery of their antimalarial drug cargo to Plasmodium-infected red blood cells. Special emphasis is placed on molecular designs that are (i) biocompatible and biodegradable, (ii) capable of encapsulating large drug amounts and of releasing them with an adequate temporal profile, and (iii) adequate for oral administration formulations.

Date

2014 Mar - 2016 Feb

Total Project Funding

$293,276

Funding Details

Project Site